Vexim (Alternext: ALVXM), co-founded by Truffle Capital (Dr Philippe Pouletty) in 2006, is the French leader in orthopaedic cements. Vexim specialises in mini-invasive solutions to treat the causes and consequences of vertebral fractures. It has specifically developed the SpineJack® implant to repair vertebral fractures. Vexim has already treated thousands of patients successfully.
Vexim was listed on Alternext in May 2012.
Dr Philippe Pouletty and Antoine Pau are Board members.